Contrary to the findings of previous studies, 800 mg/d of DHA delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to one trial.
Contrary to the findings of previous studies, 800 mg/d of docosahexaenoic acid (DHA) delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to a double-blind, randomized trial from Australia.
The study involved more than 2,000 women with singleton pregnancies of less than 21 weeks' gestation.
Researchers found that the percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the group of women who took the DHA-filled capsules versus the group who took vegetable oil capsules without DHA (9.67% vs 11.19%; adjusted relative risk [RR], 0.85; 95% CI, 0.70-1.02; P=.09).
Makrides M, Gibson RA, McPhee AJ, et al; DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More